ClinicalTrials.Veeva

Menu

Liver Regeneration After Liver Resection

NHS Trust logo

NHS Trust

Status

Unknown

Conditions

Hepatectomy
Liver Diseases

Treatments

Procedure: Liver biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT01220986
NDDC10/H0403/32

Details and patient eligibility

About

The aim of this study is to characterize Kupffer cell activity and activation of the innate immune response in the early phase of liver regeneration after right hepatectomy. The investigators hypothesise that liver regeneration after right hepatectomy in humans is associated with Kupffer cell activation and initiation of the innate immune response and that impaired liver regeneration, liver failure and sepsis following liver resection are associated with Kupffer cell dysfunction and an impaired innate immune response. The objectives for this study are to characterise Kupffer cell activity and the innate immune response in human liver before and after right hepatectomy.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients requiring right hepatectomy for colorectal liver metastases

Exclusion criteria

  • Age >75, neoadjuvant chemotherapy, recurrent disease

Trial design

20 participants in 1 patient group

Right hepatectomy
Description:
Intervals from inflow division.
Treatment:
Procedure: Liver biopsy

Trial contacts and locations

1

Loading...

Central trial contact

John S Hammond, BM.BS PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems